Daratumumab Open label, dose-escalation safety study in Combination with Lenalidomide and Dexamethasone in Patients with multiple myeloma

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005709-62

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To establish the safety profile of daratumumab when given in combination with Len/Dex in subjects with relapsed or relapsed and refractory multiple myeloma


Critère d'inclusion

  • Relapsed or Relapsed and Refractory Multiple myeloma